ATE527276T1 - Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung - Google Patents

Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung

Info

Publication number
ATE527276T1
ATE527276T1 AT02723603T AT02723603T ATE527276T1 AT E527276 T1 ATE527276 T1 AT E527276T1 AT 02723603 T AT02723603 T AT 02723603T AT 02723603 T AT02723603 T AT 02723603T AT E527276 T1 ATE527276 T1 AT E527276T1
Authority
AT
Austria
Prior art keywords
proteins
methods
production
immunogenic responses
altered immunogenic
Prior art date
Application number
AT02723603T
Other languages
English (en)
Inventor
David A Estell
Grant Ganshaw
Fiona Harding
Edmund Larenas
Ayrookaran Poulose
Elizabeth Sikorski
Russell Elliott
Original Assignee
Genencor Int
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int, Procter & Gamble filed Critical Genencor Int
Application granted granted Critical
Publication of ATE527276T1 publication Critical patent/ATE527276T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A61K2800/72—Hypo-allergenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02723603T 2001-03-23 2002-03-22 Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung ATE527276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27845901P 2001-03-23 2001-03-23
PCT/US2002/009205 WO2002077187A2 (en) 2001-03-23 2002-03-22 Proteins producing an altered immunogenic response and methods of making and using the same

Publications (1)

Publication Number Publication Date
ATE527276T1 true ATE527276T1 (de) 2011-10-15

Family

ID=23065053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02723603T ATE527276T1 (de) 2001-03-23 2002-03-22 Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung

Country Status (10)

Country Link
US (3) US6929939B2 (de)
EP (1) EP1373296B1 (de)
CN (1) CN100489094C (de)
AT (1) ATE527276T1 (de)
AU (1) AU2002254374A1 (de)
CA (1) CA2441595C (de)
DK (1) DK1373296T3 (de)
PL (1) PL210859B1 (de)
RU (1) RU2311458C2 (de)
WO (1) WO2002077187A2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA23346A1 (fr) * 1993-10-14 1995-04-01 Genencor Int Variantes de la subtilisine
ES2368718T3 (es) * 1997-10-23 2011-11-21 Danisco Us Inc. Variantes de subtilisina con múltiples sustituciones.
PL210859B1 (pl) * 2001-03-23 2012-03-30 Genencor Int Odmiana subtylizyny zawierająca zmieniony epitop limfocytów T, kwas nukleinowy kodujący tę odmianę subtylizyny, wektor ekspresyjny i komórka gospodarza zawierająca kwas nukleinowy oraz kompozycje zawierające tę odmianę subtylizyny
US20030157645A1 (en) * 2001-12-21 2003-08-21 Direvo Bio Tech Ag. Subtilisin variants with improved characteristics
US20050054843A1 (en) * 2001-12-31 2005-03-10 Estell David A Proteases producing an altered immunological response and methods of making and using the same
EP2287320B1 (de) * 2002-01-16 2014-10-01 Danisco US Inc. Mehrfach substituierte Proteasevarianten
ES2336092T3 (es) * 2002-01-16 2010-04-08 Genencor International, Inc. Variantes de proteasas con multiples sustituciones.
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20090010920A1 (en) 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US7202202B2 (en) * 2003-06-27 2007-04-10 The Procter & Gamble Company Consumable detergent composition for use in a lipophilic fluid
CA2534629C (en) * 2003-08-06 2016-01-19 University Of Maryland Biotechnology Institute Engineered proteases for affinity purification and processing of fusion proteins
US8399618B2 (en) 2004-10-21 2013-03-19 Xencor, Inc. Immunoglobulin insertions, deletions, and substitutions
US8883147B2 (en) 2004-10-21 2014-11-11 Xencor, Inc. Immunoglobulins insertions, deletions, and substitutions
US9714282B2 (en) 2003-09-26 2017-07-25 Xencor, Inc. Optimized Fc variants and methods for their generation
EP1692505B1 (de) * 2003-11-03 2012-09-05 Danisco US Inc. Cd4+-epitope von knochenmorphogeneseproteinen
AU2004297616B2 (en) 2003-12-04 2008-12-18 Xencor, Inc. Methods of generating variant proteins with increased host string content and compositions thereof
US20050164308A1 (en) * 2003-12-18 2005-07-28 Fiona Harding Beta-lactamase CD4+ T-cell epitopes
EP1737890A2 (de) 2004-03-24 2007-01-03 Xencor, Inc. Immunoglobulinvarianten ausserhalb der fc-region
US7824896B2 (en) * 2004-04-02 2010-11-02 Novozymes A/S Subtilase variants having altered lmmunogenicity
US20090060933A1 (en) * 2004-06-14 2009-03-05 Estell David A Proteases producing an altered immunogenic response and methods of making and using the same
EP2471813B1 (de) 2004-07-15 2014-12-31 Xencor, Inc. Optimierte Fc-Varianten
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
AU2005304624B2 (en) 2004-11-12 2010-10-07 Xencor, Inc. Fc variants with altered binding to FcRn
WO2006116292A2 (en) * 2005-04-27 2006-11-02 Genencor International, Inc. Methods for reducing the immunogenicity of cytokines and removal of cell surface markers
NZ563777A (en) * 2005-06-24 2010-08-27 Novozymes As Serine protease derived from Bacillus licheniformis optionally in combination with lipases and amylases for pharmaceutical use
WO2007008943A2 (en) 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
WO2007041635A2 (en) 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
EP2078077A2 (de) * 2006-10-04 2009-07-15 Codon Devices, Inc Nukleinsäurebibliotheken und ihr entwurf und herstellung
HRP20150279T1 (hr) 2007-12-26 2015-05-08 Xencor, Inc. Fc inaäśice s promijenjenim vezanjem na fcrn
US12492253B1 (en) 2008-02-25 2025-12-09 Xencor, Inc. Anti-human C5 antibodies
US20110160071A1 (en) * 2008-06-03 2011-06-30 Baynes Brian M Novel Proteins and Methods for Designing the Same
CN102046783A (zh) * 2008-06-06 2011-05-04 丹尼斯科美国公司 包含变体微生物蛋白酶的组合物和方法
EP2216392B1 (de) * 2009-02-02 2013-11-13 The Procter and Gamble Company Flüssige Handspülmittelzusammensetzung
EP2216391A1 (de) * 2009-02-02 2010-08-11 The Procter & Gamble Company Flüssige Handspülmittelzusammensetzung
ES2461892T3 (es) * 2009-02-02 2014-05-21 The Procter & Gamble Company Composición detergente líquida para lavado de vajillas a mano
ES2484002T3 (es) * 2009-02-02 2014-08-08 The Procter & Gamble Company Composición detergente líquida para lavado de vajillas a mano
EP2216390B1 (de) * 2009-02-02 2013-11-27 The Procter and Gamble Company Handspülverfahren
EP2213715A1 (de) * 2009-02-02 2010-08-04 The Procter & Gamble Company Flüssige Handspülmittelzusammensetzung
EP2414515A2 (de) * 2009-04-01 2012-02-08 Danisco US Inc. Reinigungssystem mit einer alpha-amylase und einer protease
WO2011028952A1 (en) 2009-09-02 2011-03-10 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CN102652175B (zh) 2009-12-09 2016-02-10 宝洁公司 织物和家居护理产品
AR079338A1 (es) * 2009-12-09 2012-01-18 Danisco Us Inc Variantes de proteasa de bacillus y acidos nucleicos que codifican dichas variantes
PL2558573T3 (pl) * 2010-04-15 2017-08-31 Danisco Us Inc. Kompozycje i sposoby obejmujące warianty proteazy
JP6448904B2 (ja) * 2010-05-06 2019-01-09 ダニスコ・ユーエス・インク サブチリシン変異体を含む組成物及び方法
DE102010063458A1 (de) * 2010-12-17 2012-06-21 Henkel Ag & Co. Kgaa Lagerstabiles flüssiges Wasch- oder Reinigungsmittel enthaltend Protease und Amylase
US9039689B2 (en) 2011-05-11 2015-05-26 Icecure Medical Ltd. Phase separation of cryogen in cryosurgical instrument
WO2013096948A1 (en) 2011-12-23 2013-06-27 Lydon Nicholas B Immunoglobulins and variants directed against pathogenic microbes
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
GB201212934D0 (en) * 2012-07-20 2012-09-05 Dupont Nutrition Biosci Aps Method
US12509672B2 (en) * 2018-11-28 2025-12-30 Danisco Us Inc. Subtilisin variants having improved stability

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34606A (en) * 1862-03-04 Improvement in machines for combing cotton
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
JPS5333919A (en) * 1976-09-10 1978-03-30 Nippon Steel Corp Production of cold rolled aluminum killed steel sheet with excellent deep drawability
JPS51125468A (en) 1975-03-27 1976-11-01 Sanyo Chem Ind Ltd Method of preparing resins of high water absorbency
US4152416A (en) 1976-09-17 1979-05-01 Marra Dorothea C Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness
NL190101C (nl) 1978-11-13 1993-11-01 Givaudan & Cie Sa Dibenzoylmethaanverbinding en tegen licht beschermend preparaat.
US4261868A (en) 1979-08-08 1981-04-14 Lever Brothers Company Stabilized enzymatic liquid detergent composition containing a polyalkanolamine and a boron compound
US4404128A (en) 1981-05-29 1983-09-13 The Procter & Gamble Company Enzyme detergent composition
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
JPS58144105A (ja) 1982-02-12 1983-08-27 Kurabo Ind Ltd スケ−ル除去獣毛繊維の製法
NZ208612A (en) 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5204015A (en) 1984-05-29 1993-04-20 Genencor International, Inc. Subtilisin mutants
US5185258A (en) 1984-05-29 1993-02-09 Genencor International, Inc. Subtilisin mutants
US5264366A (en) 1984-05-29 1993-11-23 Genencor, Inc. Protease deficient bacillus
US4663157A (en) 1985-02-28 1987-05-05 The Proctor & Gamble Company Sunscreen compositions
EP0209071B2 (de) * 1985-07-10 1998-07-15 Novartis AG Kontaktlinsenpflegesatz
US4990452A (en) * 1986-02-12 1991-02-05 Genex Corporation Combining mutations for stabilization of subtilisin
IE65767B1 (en) 1986-04-30 1995-11-15 Genencor Int Non-human carbonyl hydrolase mutants DNA sequences and vectors encoding same and hosts transformed with said vectors
US4937370A (en) 1987-06-02 1990-06-26 The Procter & Gamble Company Novel chromophores, sunscreen compositions and methods for preventing sunburn
US4999186A (en) 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
US4914031A (en) * 1987-04-10 1990-04-03 Amgen, Inc. Subtilisin analogs
DE3856315T2 (de) 1987-10-22 1999-10-14 The Procter & Gamble Co. Chelatbildner enthaltende Lichtschutzmittel
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
US5116741A (en) * 1988-04-12 1992-05-26 Genex Corporation Biosynthetic uses of thermostable proteases
US5087372A (en) 1989-03-24 1992-02-11 Asahi Kasei Kogyo Kabushiki Kaisha Method for removing heavy metal ions from contaminated water and a porous membrane usable therefor
KR100188532B1 (ko) * 1989-05-17 1999-06-01 스티븐 엠. 오드리 돌연변이 섭티리신 및 그를 함유하는 조성물
US5665587A (en) * 1989-06-26 1997-09-09 Novo Nordisk A/S Modified subtilisins and detergent compositions containing same
US5011681A (en) 1989-10-11 1991-04-30 Richardson-Vicks, Inc. Facial cleansing compositions
US5264365A (en) * 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
FI932561L (fi) * 1990-12-05 1993-06-04 Novo Nordisk As Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning
DK132892D0 (da) 1992-10-30 1992-10-30 Novo Nordisk As Proteiner
DE69434962T2 (de) * 1993-10-14 2008-01-17 The Procter & Gamble Company, Cincinnati Proteasehaltige reinigungsmittel
EP0723580B1 (de) * 1993-10-14 2003-07-16 The Procter & Gamble Company Proteasen enthaltende bleichmittelzusammensetzungen
MA23346A1 (fr) * 1993-10-14 1995-04-01 Genencor Int Variantes de la subtilisine
FR2712286B1 (fr) * 1993-11-12 1995-12-22 Oreal Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
US6068834A (en) 1994-03-04 2000-05-30 The Procter & Gamble Company Skin lightening compositions
FR2719481B1 (fr) 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
CZ365996A3 (en) 1994-06-15 1997-10-15 Procter & Gamble Use of mercapto derivatives for preparing pharmaceutical preparation for making lighter of skin
GB9415421D0 (en) 1994-07-30 1994-09-21 Procter & Gamble Cosmetic compositions and processes for manufacture thereof
MX9703895A (es) 1994-11-28 1997-08-30 Procter & Gamble Composiciones topicas para el cuidado de la piel que contienen esteres de acido carboxilico de poliol espesado como agentes de acondicionamiento de la piel.
FI972443A7 (fi) 1994-12-07 1997-06-09 Novozymes As Polypeptidi, jonka allergeenisuus on vähentynyt
WO1996040791A1 (en) 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides
CN1273589C (zh) 1996-02-15 2006-09-06 诺沃奇梅兹有限公司 多肽缀合
US5627508A (en) * 1996-05-10 1997-05-06 The United States Of America As Represented By The Secretary Of The Navy Pilot vehicle which is useful for monitoring hazardous conditions on railroad tracks
US5827508A (en) 1996-09-27 1998-10-27 The Procter & Gamble Company Stable photoprotective compositions
CA2272306A1 (en) 1996-11-22 1998-05-28 The Procter & Gamble Company Cosmetic compositions
US5966485A (en) * 1996-11-22 1999-10-12 Siecor Corporation Method of producing core protrusion relative to cladding in an optical fiber of a fiber optic connector
AR015977A1 (es) * 1997-10-23 2001-05-30 Genencor Int Variantes de proteasa multiplemente substituida con carga neta alterada para su empleo en detergentes
US6569663B1 (en) 1998-03-26 2003-05-27 The Procter & Gamble Company Serine protease variants having amino acid substitutions
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US5935556A (en) 1998-07-30 1999-08-10 The Procter & Gamble Company Sunscreen compositions
US5989528A (en) 1998-07-30 1999-11-23 The Procter & Gamble Company Sunscreen compositions
US5972316A (en) 1998-10-16 1999-10-26 The Procter & Gamble Company UV protection compositions
US5968485A (en) 1998-10-16 1999-10-19 The Procter & Gamble Company UV protection compositions
WO2000024371A1 (en) 1998-10-23 2000-05-04 The Procter & Gamble Company Skin care compositions
BR0012660A (pt) * 1999-07-22 2002-04-09 Procter & Gamble Variante de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
US6428799B1 (en) * 1999-08-02 2002-08-06 The Procter & Gamble Company Personal care articles
US6815865B2 (en) 2000-01-31 2004-11-09 Seralco Microtechnology Ltd. Switching arrangement for a radiation guide
US20030170846A1 (en) * 2000-04-24 2003-09-11 Weisgerber David John Enzyme variants having one or more D-amino acid substitutions
CA2424720C (en) 2000-10-02 2012-04-03 Genencor International, Inc. Proteins producing an altered immunogenic response and methods of making and using the same
PL210859B1 (pl) * 2001-03-23 2012-03-30 Genencor Int Odmiana subtylizyny zawierająca zmieniony epitop limfocytów T, kwas nukleinowy kodujący tę odmianę subtylizyny, wektor ekspresyjny i komórka gospodarza zawierająca kwas nukleinowy oraz kompozycje zawierające tę odmianę subtylizyny

Also Published As

Publication number Publication date
DK1373296T3 (da) 2012-01-09
AU2002254374A1 (en) 2002-10-08
WO2002077187A2 (en) 2002-10-03
EP1373296B1 (de) 2011-10-05
EP1373296A2 (de) 2004-01-02
WO2002077187A3 (en) 2003-04-24
CA2441595A1 (en) 2002-10-03
US20030118605A1 (en) 2003-06-26
US20050202551A1 (en) 2005-09-15
RU2003131177A (ru) 2005-01-20
CA2441595C (en) 2012-07-03
HK1061566A1 (en) 2004-09-24
PL210859B1 (pl) 2012-03-30
RU2311458C2 (ru) 2007-11-27
US6929939B2 (en) 2005-08-16
PL364138A1 (en) 2004-12-13
CN100489094C (zh) 2009-05-20
US20050202552A1 (en) 2005-09-15
US7476528B2 (en) 2009-01-13
EP1373296A4 (de) 2007-03-28
CN1512998A (zh) 2004-07-14

Similar Documents

Publication Publication Date Title
ATE527276T1 (de) Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung
BR0215383A (pt) proteases que produzem resposta imunogênica alterada e métodos de fabricação e uso das mesmas
WO2005063820A3 (en) Il-7 fusion proteins
ATE278010T1 (de) Methode um proteine aus einem einzeller zu extrahieren
EP2277888A3 (de) Fusionsprotein von Albumin und Erythropoietin
WO2005003296A3 (en) Albumin fusion proteins
ATE532860T1 (de) B7-ähnliche moleküle und deren anwendungen
AU2001254624A1 (en) Human coagulation factor vii variants
DE69840704D1 (de) Nukleinsäuremoleküle, welche für proteine kodieren, die fructosyltransferase-aktivität aufweisen und verfahren zur herstellung von langkettigem inulin
WO2005063819A3 (en) Human binding molecule against cd1a
EP2298355A3 (de) Albuminfusionsproteine
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
DE602004008386D1 (de) System und Methode zur Herstellung von Brillengläsern, Programm und Medium
ATE323766T1 (de) Glykosylierte leptinzusammensetzungen und zugehörige verfahren
ATE195346T1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
WO2000053776A3 (en) Human kallikrein-like genes
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
ATE533837T1 (de) Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen
DE10294286D2 (de) Herstellung von trägergebundenen Molekülen
WO2000068364A3 (en) Mutations in nucleic acid molecules encoding 11-cis retinol dehydrogenase, the mutated proteins, and uses thereof
DK1412503T3 (da) Et fusionsprotein
WO2004089982A3 (en) April variants and methods thereof
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2003060092A3 (en) Modified fatty acid hydroxylase protein and genes
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties